Evaluation of lorazepam as an anxiolytic agent in psychiatric practice.
D000328:Adult; D000368:Aged; D001007:Anxiety / Q000188:drug therapy*; D001570:Benzodiazepinones / Q000009:adverse effects / Q000627:therapeutic use*; D002722:Chlorobenzenes / Q000009:adverse effects / Q000627:therapeutic use; D003863:Depression / Q000188:drug therapy; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009771:Obsessive-Compulsive Disorder / Q000188:drug therapy; D011569:Psychiatric Status Rating Scales; D012559:Schizophrenia / Q000188:drug therapy; D007319:Sleep Initiation and Maintenance Disorders / Q000188:drug therapy; D014149:Tranquilizing Agents / Q000009:adverse effects / Q000627:therapeutic use*
D001570:Benzodiazepinones; D002722:Chlorobenzenes; D014149:Tranquilizing Agents